Pfizer’s German development partner BioNTech on Thursday joined other leading COVID-19 vaccine developers in ruling out participation in British plans to test experimental inoculations by deliberately infecting trial volunteers. “BioNTech’s vaccine candidate is not part of this study,” a spokeswoman said. Britain is planning to host so-called “challenge trials”, the Financial Times cited people involved in the project as saying.
